Category: Drug Safety Alerts
-
New Medical Study About SSRI Antidepressants Used During Pregnancy And Autism Spectrum Disorder (ASD) In Children
JAMA Pediatrics Article Reports Increased Risk Is Greatest When These Depression Medicines Are Used By Mothers During The Second And/Or Third Trimester (Posted by Tom Lamb at DrugInjuryWatch.com) Some popular medications prescribed…
-
FDA Adds Ketoacidosis Warnings To Diabetes Drugs Invokana, Farxiga, And Jardiance As Well As Other SGLT2 Inhibitors
This Follows October 2015 Safety Alert By Health Canada Concerning Increased Risks Of Kidney Problems (Posted by Tom Lamb at DrugInjuryWatch.com) ________________________________________________________________________________ UPDATE: “Health Canada Warns About Link Between DKA & Popular Diabetes…
-
Hepatitis C Drugs Viekira Pak And Technivie Require Warnings Label Changes Due To Liver Injury Reports
FDA Says The Timing Of Liver Injury Suggests That These Are Side Effects, Especially In Patients With Advanced Cirrhosis (Posted by Tom Lamb at DrugInjuryWatch.com) Viekira Pak and Technivie are relatively new…
-
Xarelto, Savaysa, Pradaxa, And Eliquis: Safety Secondary To Ease Of Use Is “A Major Wrong Turn” Says Drug Watchdog Group
This New Generation Of Oral Anticoagulants Has Bleeding-Related Adverse Reactions Including Gastrointestinal And Intracranial Bleeds (Posted by Tom Lamb at DrugInjuryWatch.com) The ISMP QuarterWatch published on September 23, 2015 includes an examination…
-
Potential Link Between MS Drug Gilenya And Cancers, Neoplasms, Or Tumors According To Health Canada
This September 2015 Drug Safety Alert Is Based Primarily On Reports Of Skin Cancer And Lymphoma Blood Cancer (Posted by Tom Lamb at DrugInjuryWatch.com) Health Canada recently conducted a review of safety…
-
Xarelto: Drug-Induced Liver Injury Reports Received By Health Canada And Found In Medical Literature
Should New Liver Side Effects Warning Be Added By Janssen Pharmaceuticals To Prescribing Information For Xarelto? (Posted by Tom Lamb at DrugInjuryWatch.com) In the August 2015 edition of the Health Product InfoWatch…
-
New FDA Warning That Januvia, Onglyza, Tradjenta, And Nesina Are Associated With “joint pain that can be severe and disabling”
Label Changes About Side Effects For These Type 2 Diabetes Medicines In The Drug Class Called Dipeptidyl Peptidase-4 (DPP-4) Inhibitors (Posted by Tom Lamb at DrugInjuryWatch.com) In August 2015 the FDA announced…
-
August 2015 Gilenya Label Change About PML Brain Infection Follows FDA Drug Safety Alert About This Serious Side Effect
These Two PML Cases Did Not Involve The Patients Previously Using The MS Drug Tysabri, As Did The One Which FDA Reported In August 2013 (Posted by Tom Lamb at DrugInjuryWatch.com) ________________________________…
-
Will There Be Another Drug Label Change For YAZ And Other Drospirenone (DRSP) Birth Control Pills, As FDA Required For Ortho Evra Years Ago
Since Bayer Revised YAZ Label In April 2012 There Has Been More Medical Evidence That DRSP Pills Increase Risks Of Blood Clot Side Effects Like DVT And PE (Posted by Tom Lamb at…